"It never was my thinking that made the big money for me. It always was the sitting. Got that? My sitting tight!" - Reminiscences of a Stock Operator -
Recent FEMY News
- Femasys Expands Commercial Management Team with Addition of Experienced New Hires • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives • GlobeNewswire Inc. • 04/18/2024 12:30:00 PM
- Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape • GlobeNewswire Inc. • 03/21/2024 01:00:00 PM
- Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility • GlobeNewswire Inc. • 03/20/2024 12:15:00 PM
- Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 • GlobeNewswire Inc. • 03/13/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:09:27 PM
- Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution • GlobeNewswire Inc. • 03/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:16:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 02:47:58 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 02:44:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:47:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:43:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:42:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:42:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/11/2023 05:15:27 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/08/2023 02:28:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/30/2023 10:17:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:05:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:39:26 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:33:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 10:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 10:19:52 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM